Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Psoriasis

5,8,11,14-eicosatetraynoic acid has been researched along with Psoriasis in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ziboh, VA1
Casebolt, TL1
Marcelo, CL1
Voorhees, JJ1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Psoriasis

ArticleYear
Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    The Journal of investigative dermatology, 1984, Volume: 83, Issue:6

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Arachidonate Lipoxygena

1984